- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
G6PD (aa 305 - 318) AntibodyPeptide-affinity purified goat antibody
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AF1453a | 0.1mg 400 ul | 7-10 days | $ 325.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
G6PD (aa 305 - 318) Antibody - Product info | |
| Other Accession | NP_001035810 |
| Reactivity | Human |
| Concentration | 100ug/200ul |
| Isotype | IgG |
G6PD (aa 305 - 318) Antibody - Additional info | |
| Other Names G6PD; glucose-6-phosphate dehydrogenase ; G6PD1 ; glucose-6-phosphate 1-dehydrogenase; glucose-6-phosphate dehydrogenase; G6PD | |
| Format 0.5 mg IgG/ml in Tris saline (20mM Tris pH7.3, 150mM NaCl), 0.02% sodium azide, with 0.5% bovine serum albumin | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions G6PD (aa 305 - 318) Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
G6PD (aa 305 - 318) Antibody - Application data
-
AF1453a (1 µg/ml) staining of Peripheral Blood Mononucleocytes lysate (35 µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
G6PD (aa 305 - 318) Antibody - Related products
AP5094c: G6PD Antibody (Center)
BP5094c: G6PD Antibody (Center) Blocking Peptide
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene.
REFERENCES
Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086. Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. Al-Allawi N, et al. BMC Blood Disord, 2010 Jul 5. PMID 20602793. A novel G473A mutation in the glucose-6-phosphate dehydrogenase gene. Chen X, et al. Pediatr Blood Cancer, 2010 Aug. PMID 20582980. Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia. Nouraie M, et al. Br J Haematol, 2010 Jul. PMID 20507315. Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring. Eid NA, et al. Malar J, 2010 May 8. PMID 20459687.
